|
注册号: Registration number: |
ChiCTR2500101829 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-30 09:15:12 |
|
注册时间: Date of Registration: |
2025-04-30 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
反馈训练结合呼吸训练治疗周围神经损伤疗效观察 |
|
Public title: |
The efficacy of feedback training combined with respiratory training in the treatment of peripheral nerve injury |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
反馈训练结合呼吸训练治疗周围神经损伤疗效观察 |
|
Scientific title: |
The efficacy of feedback training combined with respiratory training in the treatment of peripheral nerve injury |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
褚晓蕾 |
研究负责人: |
李奇 |
|
Applicant: |
Xiaolei Chu |
Study leader: |
Qi Li |
|
申请注册联系人电话: Applicant telephone: |
+86 150 2209 6747 |
研究负责人电话:
Study leader's |
+86 150 2209 5665 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
Liqi_82@126.com |
研究负责人电子邮件: Study leader's E-mail: |
Liqi_82@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
天津市河西区解放南路406号 |
研究负责人通讯地址: |
天津市河西区解放南路406号 |
|
Applicant address: |
No. 406, Jiefang South Road, Hexi District, Tianjin |
Study leader's address: |
No. 406, Jiefang South Road, Hexi District, Tianjin |
|
申请注册联系人邮政编码: Applicant postcode: |
300211 |
研究负责人邮政编码: Study leader's postcode: |
300211 |
|
申请人所在单位: |
天津市天津医院 |
||
|
Applicant's institution: |
Tianjin Hospital, Tianjin City |
||
|
研究负责人所在单位: |
天津市天津医院 |
||
|
Affiliation of the Leader: |
Tianjin Hospital, Tianjin City |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025医伦审002 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
天津市天津医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Tianjin Hospital, Tianjin, China |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-03-26 00:00:00 | ||
|
伦理委员会联系人: |
戴斌 |
||
|
Contact Name of the ethic committee: |
Bin Dai |
||
|
伦理委员会联系地址: |
天津市河西区解放南路406号 |
||
|
Contact Address of the ethic committee: |
No. 406, Jiefang South Road, Hexi District, Tianjin |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 177 2003 4985 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
天津市天津医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Tianjin Hospital, Tianjin City |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
天津市河西区解放南路406号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 406, Jiefang South Road, Hexi District, Tianjin |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-raised funds |
||||||||||||||||||||||
|
研究疾病: |
周围神经损伤 |
||||||||||||||||||||||
|
Target disease: |
Peripheral nerve injury |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究拟在通过将肌电反馈与镜像疗法及呼吸训练进行结合,在基于镜像的肌电反馈训练的过程中进行呼吸训练。即基于镜像的肌电反馈训练改善患者的功能,呼吸训练缓解患者的疼痛,从而形成一种系统的治疗方法,在多方面调节患者的生理和心理状态。在促进功能恢复的同时,减轻周围神经损伤后引发的疼痛,提升整体治疗效果,进一步提高对于周围神经损伤患者的疗效。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study proposes to conduct breathing training during mirror-based EMG feedback training by combining EMG feedback with mirror therapy and breathing training. In other words, mirror-based EMG feedback training improves patients' function and respiratory training relieves patients' pain, thus forming a systematic treatment method that regulates patients' physiological and psychological status in various aspects. In addition to promoting functional recovery, it also reduces the pain caused by peripheral nerve injury, improves the overall therapeutic effect, and further improves the therapeutic efficacy for patients with peripheral nerve injury. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.骨折未愈合 2.任何会影响患者遵守研究方案能力的心理或医学状况 3.存在大量静脉血栓 4.单侧忽视或偏盲等视知觉障碍者 5.严重高血压(>=2级) 6.有失用症的患者 7.坐床角度<=45° 8.认知、言语功能障碍 9.患者及家属不合作,不能配合完成实验的患者 10.严重的肺部疾病(如肺气肿、重度哮喘)、癫痫、肺结核或其他传染性疾病、易呼吸性酸中毒的患者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Fracture did not heal 2. Any psychological or medical condition that may affect the patient's ability to adhere to the study protocol 3. The presence of massive venous thrombosis 4. Patients with visual perception disorders such as unilateral neglect or hemianopia 5. Severe hypertension (>= grade 2) 6. Patients with apraxia 7. Bed Angle <=45° 8. Cognitive and speech dysfunction 9. Patients and their families do not cooperate and cannot cooperate to complete the experiment 10. Patients with severe lung diseases (such as emphysema, severe asthma), epilepsy, tuberculosis or other infectious diseases, or prone to respiratory acidosis; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-01 00:00:00至 To 2028-04-05 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-05-20 00:00:00 至 To 2028-01-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机生成包含组别信息的编码卡,将每张卡片密封于编号连续、不透明且防篡改的信封内(通常采用双层信封设计,外层仅标注受试者唯一识别码),信封封口处需加盖骑缝章或采用电子密封贴纸;在受试者符合入组条件时,研究者按顺序拆封对应编号的信封,拆封过程需在监督员见证下进行,并实时记录拆封时间、环境及操作人员信息。为确保隐蔽性,信封材质需完全遮光以防止透视,且禁止提前批量拆封或重复使用信封。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Randomly generate coded cards containing group information, and seal each card in a consecutively numbered, opaque and tamper-proof envelope (usually with a double-layer envelope design, with only the subject's unique identifier labeled on the outer layer), with the seal of the envelope stamped with a sealing seal or an electronic sealing sticker; when subjects meet the conditions for enrollment, the researcher will open the envelopes corresponding to the numbered envelopes sequentially, and the process of opening the envelopes should be carried out in the presence of a supervisor, with real-time recording of the time, environment and operator information. The opening process should be witnessed by a supervisor, and the time, environment and operator information should be recorded in real time. In order to ensure concealment, the envelopes should be made of a material that is completely shielded from light to prevent visualization, and it is prohibited to open the envelopes in advance or reuse the envelopes in bulk. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2028-04-05,Clinical Trial Management Public Platform, http://www.medresman.org.cn. |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2028-04-05,Clinical Trial Management Public Platform, http://www.medresman.org.cn. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病历记录表和评估表及检测表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Medical history record forms and assessment and testing forms |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |